Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| FULC | INST-CLUSTER | mixed | 5/10 | A mixed institutional cluster in FULC for Q4 2025 shows $41.9M in net buying concentrated in two new/large quant positio | Jun 11, 2026 |
| OMER | INST-CLUSTER | neutral | 4/10 | Three institutions (Citadel, Two Sigma, Morgan Stanley) accumulated $7.0M in OMER during Q3 2025, while D.E. Shaw trimme | Jun 11, 2026 |
| BCAX | INST-CLUSTER | bearish | 5/10 | An institutional cluster for Bicara Therapeutics (BCAX) shows net bearish conviction in Q3 2025: 3 sellers (including a | Jun 11, 2026 |
| TNGX | INST-CLUSTER | bullish | 5/10 | A strong institutional accumulation cluster emerged in TNGX during Q3 2025, with 10 funds net buying $96.6M vs. 2 seller | Jun 11, 2026 |
| TECX | INST-CLUSTER | bullish | 4/10 | Six institutional investors accumulated $4.0M in TECX during Q3 2025, led by Point72 (+$2.0M) and Citadel (+$1.4M), whil | Jun 11, 2026 |
| LENZ | INST-CLUSTER | bullish | 6/10 | A clear bullish institutional cluster emerged in LENZ during Q3 2025: 8 buyers (net +$108.9M) vs 3 sellers (net -$5.8M). | Jun 11, 2026 |
| ALEC | INST-CLUSTER | neutral | 4/10 | Institutional cluster for ALEC shows 5 active/quant funds adding $6.7M in positions while 3 passive funds trimmed $683K | Jun 11, 2026 |
| TRVI | INST-CLUSTER | mixed | 4/10 | A strong institutional cluster for Trevi Therapeutics (TRVI) in Q3 2025 shows 8 buyers adding $111.4M in aggregate holdi | Jun 11, 2026 |
| CSTL | INST-CLUSTER | bearish | 5/10 | Institutional cluster for CSTL reveals 5 sellers (notably Citadel trimming 71.8% of its stake) vs 2 passive buyers, resu | Jun 11, 2026 |
| ACHV | INST-CLUSTER | bearish | 5/10 | A mixed institutional cluster in ACHV for Q3 2025: two mega-passive buyers (State Street, BofA) added small positions to | Jun 11, 2026 |
| CATX | INST-CLUSTER | neutral | 4/10 | Q4 2025 13F cluster for CATX shows a mixed institutional picture: two mega-passive funds (Fidelity, BofA) aggressively r | Jun 11, 2026 |
| CRDF | INST-CLUSTER | bearish | 4/10 | Four major institutions reduced CRDF holdings in Q3 2025, with Morgan Stanley, BofA, Two Sigma, and Nuveen collectively | Jun 11, 2026 |
| MBX | INST-CLUSTER | bullish | 5/10 | A major institutional cluster in MBX Biosciences shows 10 funds adding $105.9M in holdings (led by BlackRock +$57.8M and | Jun 11, 2026 |
| SUPN | INST-CLUSTER | neutral | 3/10 | Institutional cluster for SUPN shows mixed activity in Q4 2025: three buyers (Wells Fargo, Morgan Stanley, Point72) adde | Jun 11, 2026 |
| ADIL | PRESS-RELEASE | bullish | 7/10 | Adial Pharmaceuticals acquires Azora Therapeutics and secures up to $64M in private placement, pivoting to a colon-targe | Jun 11, 2026 |
| INBX | INST-CLUSTER | neutral | 3/10 | Three passive mega-managers (Morgan Stanley, Invesco, BofA) accumulated $15.4M in INBX during Q3 2025, led by Morgan Sta | Jun 11, 2026 |
| AMRX | INST-CLUSTER | mixed | 4/10 | Two mega-passives (Morgan Stanley, Invesco) and two quants (D.E. Shaw, Two Sigma) added $31M in AMRX during Q3, while tw | Jun 11, 2026 |
| ATYR | INST-CLUSTER | mixed | 4/10 | 6 major financial institutions (D.E. Shaw, Two Sigma, and 4 passive managers) collectively doubled or tripled their ATYR | Jun 11, 2026 |
| IVVD | INST-CLUSTER | mixed | 4/10 | In 2025-Q3, a mixed institutional cluster formed in IVVD: 6 buyers added $26.7M (dominated by Point72's new $22.3M posit | Jun 11, 2026 |
| GPCR | INST-CLUSTER | bearish | 5/10 | A mixed institutional cluster in GPCR (2025-Q3) shows 4 buyers adding a net $6.0M against 3 sellers reducing by $51.6M. | Jun 11, 2026 |
| HROW | INST-CLUSTER | mixed | 4/10 | An institutional cluster in HROW for Q3 2025 shows a net mixed conviction: three asset managers (dominated by Dimensiona | Jun 11, 2026 |
| CRVS | INST-CLUSTER | neutral | 3/10 | An institutional cluster formed in CRVS during 2025-Q3, with five institutions, including State Street, Fidelity, and We | Jun 11, 2026 |
| GSK | 6-K | neutral | 1/10 | GSK filed a routine Form 6-K on June 11, 2026, disclosing eight PDMR transactions under the company's Share Reward Plan. | Jun 11, 2026 |
| CTKB | INST-CLUSTER | bearish | 5/10 | An institutional cluster in Cytek Biosciences (CTKB) for Q3 2025 shows mixed conviction: two passive managers added $1.4 | Jun 11, 2026 |
| ACAD | INST-CLUSTER | bearish | 6/10 | A bearish institutional cluster emerged in ACAD during Q3 2025: 5 major sellers reduced holdings by ~$192.7M while only | Jun 11, 2026 |
| ERAS | INST-CLUSTER | mixed | 4/10 | Three large passive/asset manager institutions trimmed their Erasca positions in 2025-Q3, while two firms (Invesco and R | Jun 11, 2026 |
| MLYS | INST-CLUSTER | bullish | 6/10 | A strong institutional cluster formed in MLYS during Q3 2025, with 12 buyers accumulating $421.7M in net new positions v | Jun 11, 2026 |
| SRPT | INST-CLUSTER | mixed | 4/10 | An institutional cluster in SRPT shows 6 buyers (adding $99M) and 5 sellers (reducing $102.8M) in Q3 2025, resulting in | Jun 11, 2026 |
| VTGN | INST-CLUSTER | bullish | 5/10 | Five institutional investors, including Renaissance Technologies and Two Sigma, significantly increased their positions | Jun 11, 2026 |
| RIGL | INST-CLUSTER | neutral | 3/10 | Mixed institutional cluster for RIGL in Q3 2025: six funds (mostly passive + quants) added $21.8M, while three passive s | Jun 11, 2026 |